Now Health Medical (02225): Partnering with Sinopharm Ling Commerce to accelerate the commercialization process of high-end medical instruments.

Jinhai Medical Fabric announced that its subsidiary Jinhai Xiehuan Medical has reached a commercial cooperation with Sinopharm Lingbing, authorizing Sinopharm Lingbing as the exclusive distributor of the company's high-end medical instruments in China.

Zhitong FinanceJan 3 09:25 ET

Jinhai Medical Partners With Sinopharm for China Expansion

TipRanksJan 3 04:09 ET

JINHAI MED TECH (02225.HK) has signed a master sales agreement with China National Pharmaceutical Group.

On January 3, Gelonghui reported that JINHAI MED TECH (02225.HK) announced that its wholly-owned subsidiary Shanghai JINHAI Xiehuan Medical Technology Co., Ltd. ("JINHAI Xiehuan") has recently entered into a total sales agreement with SINOPHARM Lingshang Hospital Management Service (Shanghai) Co., Ltd. ("SINOPHARM Lingshang"). According to this agreement, JINHAI Xiehuan authorizes SINOPHARM Lingshang as the exclusive distributor for several high-end medical instruments of the group in China, valid until October 2025. SINOPHARM Lingshang is a joint venture established by SINOPHARM and Mitsubishi Corporation of Japan. As a comprehensive operation service provider for medical consumables, SINOPHARM.

Gelonghui FinanceJan 3 04:05 ET

Express News | Jinhai Medical Technology - Unit Authorized Sinopharm Lingshang as Exclusive Distributor of Certain High-Ended Medical Devices in PRC up to Oct

ReutersJan 3 04:02 ET

Jinhai Medical Resolves High Shareholding Concentration

TipRanksDec 31, 2024 06:39 ET

JINHAI MED TECH (02225.HK) does not have its shares concentrated in a few Shareholders.

Gelonghui, December 31 | JINHAI MED TECH (02225.HK) announced that the company believes that the concerns regarding the High Ownership situation mentioned in the CSRC announcement no longer exist as of December 9, 2024. The High Ownership situation referred to in the CSRC announcement should not be used as a basis for evaluating the current state of the company's ownership structure. The Board of Directors believes that, based on the analysis results, (i) the High Ownership situation of the company mentioned in the CSRC announcement on November 20, 2024, no longer exists as of December 9, 2024; and (ii) the company's ownership is not concentrated among a very small number of Shareholders.

Gelonghui FinanceDec 31, 2024 06:16 ET